Studies on the mechanism of toxicity of the organophosphorus pesticide triamiphos

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY European journal of pharmacology Pub Date : 1971-11-01 DOI:10.1016/0014-2999(71)90039-2
R. Lauwerys, J.-P. Buchet
{"title":"Studies on the mechanism of toxicity of the organophosphorus pesticide triamiphos","authors":"R. Lauwerys,&nbsp;J.-P. Buchet","doi":"10.1016/0014-2999(71)90039-2","DOIUrl":null,"url":null,"abstract":"<div><p>The i.p. LD<sub>5 0</sub> of the organophosphorus ester triamiphos to adult male rat is about 15 mg/kg. The symptoms are typical of peripheral cholinesterase inhibition. Thus death is due to respiratory paralysis; there is no stimulation of the central nervous system. Measurement of the cholinesterase activity of several tissues after i.p. administration of various doses of triamiphos indicates that: (1) the rapidity of true cholinesterase inhibition at the myoneural junction is a major factor in the outcome of the acute intoxication; (2) brain true cholinesterase is not significantly inhibited; (3) in vivo, pseudocholinesterase is more inhibited than true cholinesterase; (4) except in the intestine, no return of cholinesterase activity was observed within 18 hr following the injection. Triamiphos is not a direct cholinesterase inhibitor but conversion by the liver to an anticholinesterase agent has been demonstrated by incubation of triamiphos with a fortified liver preparation. The active metabolite is very labile and does not readily cross the blood brain-barrier.</p></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"16 3","pages":"Pages 361-366"},"PeriodicalIF":4.7000,"publicationDate":"1971-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0014-2999(71)90039-2","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0014299971900392","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 6

Abstract

The i.p. LD5 0 of the organophosphorus ester triamiphos to adult male rat is about 15 mg/kg. The symptoms are typical of peripheral cholinesterase inhibition. Thus death is due to respiratory paralysis; there is no stimulation of the central nervous system. Measurement of the cholinesterase activity of several tissues after i.p. administration of various doses of triamiphos indicates that: (1) the rapidity of true cholinesterase inhibition at the myoneural junction is a major factor in the outcome of the acute intoxication; (2) brain true cholinesterase is not significantly inhibited; (3) in vivo, pseudocholinesterase is more inhibited than true cholinesterase; (4) except in the intestine, no return of cholinesterase activity was observed within 18 hr following the injection. Triamiphos is not a direct cholinesterase inhibitor but conversion by the liver to an anticholinesterase agent has been demonstrated by incubation of triamiphos with a fortified liver preparation. The active metabolite is very labile and does not readily cross the blood brain-barrier.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
有机磷农药三磷的毒性机制研究
三磷酸有机磷酯对成年雄性大鼠的ld50约为15 mg/kg。症状是典型的外周胆碱酯酶抑制。因此,死亡是由于呼吸麻痹;对中枢神经系统没有刺激。对不同剂量三氨磷灌胃后几种组织胆碱酯酶活性的测定表明:(1)肌神经交界处胆碱酯酶真正抑制的速度是急性中毒结果的主要因素;(2)脑真胆碱酯酶未明显抑制;(3)体内假胆碱酯酶比真胆碱酯酶受到更大的抑制;(4)除肠道外,注射后18小时内胆碱酯酶活性未见恢复。Triamiphos不是直接的胆碱酯酶抑制剂,但通过Triamiphos与强化肝脏制剂的孵育已经证明了肝脏转化为抗胆碱酯酶剂。活性代谢物非常不稳定,不易穿过血脑屏障。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
期刊最新文献
Corrigendum to "Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist" [Eur. J. Pharmacol. 650 (2011) 58-63]. Corrigendum to "Therapeutic effects of methotrexate encapsulated in hyaluronic acid-coated exosomes derived from Wharton's jelly mesenchymal stem cells in a rat model of rheumatoid arthritis" [Eur. J. Pharmacol. 1015, 15 (February 2026), 178610]. Corrigendum to "Topiroxostat improves glomerulosclerosis in type 2 diabetic Nagoya Shibata Yasuda mice with early diabetic kidney disease" [Eur. J. Pharmacol. 982 (2024) 176915]. From Neuropsychiatric Use to Oncology: Repurposing Antipsychotic Drugs for Cancer Treatment. LncRNA NR_190073.1 Mediates the Cardioprotective Effect of Ulinastatin in Sepsis through Notch Signaling.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1